Waterbury : Chase Medical Research, LLC
A Six Month Phase II/III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Telcagepant (MK-0974) for Prevention of Menstrually Related Migraine in Female Patients with Episodic Migraine.
Mt Pleasant : Coastal Carolina Research Center
Menstrual Migraine Headache Clinical Research Study